EW241220P90000
- 0.00
- 0.000.00%
Edwards Lifesciences Newsroom
Edwards Lifesciences (EW) Receives a Hold From Leerink Partners
Wednesday Ends With Index Decline | Wall Street Today
The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts
Edwards Lifesciences Analyst Ratings
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
RBC Capital Maintains Edwards Lifesciences(EW.US) With Buy Rating, Raises Target Price to $80
RBC Raises Price Target on Edwards Lifesciences to $80 From $75, Keeps Outperform Rating
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
A Look At The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Hold Rating Maintained on Edwards Lifesciences Despite Positive SAPIEN 3 Ultra RESILIA Valve Data
S&P 500, Dow Hit Records Right After Open | Live Stock
Express News | Edwards Lifesciences Corp : Leerink Partners Raises Target Price to $74 From $73
Piper Sandler Reaffirms Their Hold Rating on Edwards Lifesciences (EW)
Edwards Lifesciences Announces Presentation of One-year SAPIEN 3 Data
Edwards Lifesciences Says Latest Heart Valve Shows Improved Outcomes Over Older Models
Edwards' SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
Despite Delivering Investors Losses of 39% Over the Past 3 Years, Edwards Lifesciences (NYSE:EW) Has Been Growing Its Earnings